L & D COCHRANE SIGNALLING LTD

Executive Summary

L & D Cochrane Signalling Ltd is a micro-entity in its start-up phase with a fragile financial position marked by minimal equity and tight working capital. The company is currently sustaining operations mainly through director loans, reflecting typical early-stage funding patterns. Strengthening equity, improving liquidity buffers, and formalizing financing arrangements will be critical to ensuring long-term financial health and resilience.

L & D COCHRANE SIGNALLING LTD - Analysis Report

Company Number: 15238011

Analysis Date: 2025-07-20 17:59 UTC

Financial Health Assessment Report for L & D Cochrane Signalling Ltd

---

1. Financial Health Score: C

Explanation:
The company is in its infancy (incorporated October 2023) with very modest financial figures reflecting a start-up phase. The balance sheet shows a near-breakeven position with minimal net assets (£2), indicating a very thin equity base. While the company has positive net current assets (£502), the overall financial strength is limited. The presence of director loans suggests reliance on internal funding rather than external financing, which is typical for micro-entities but points to limited liquidity buffers. This results in a fair but cautious grade—adequate to operate but with evident vulnerabilities.

---

2. Key Vital Signs

Metric	Value	Interpretation
Current Assets	£18,845	Cash/debtors/stock available to cover short-term debts. Healthy liquidity for a micro business.
Current Liabilities	£18,343	Obligations due within one year nearly equal current assets, leaving a very narrow working capital margin.
Net Current Assets (Working Capital)	£502	Positive but very slim, indicating limited buffer to absorb short-term shocks.
Net Assets (Equity)	£2	Extremely low equity, reflects initial capital and minimal retained earnings; fragile capital base.
Share Capital	£2	Nominal share capital, typical for micro companies but minimal shareholder investment.
Director Loans Outstanding	£7,080	Reliance on director funding; interest-free and repayable on demand, indicating informal financing.

---

3. Diagnosis: Financial Health Overview

L & D Cochrane Signalling Ltd is in the early stages of its life cycle, showing symptoms akin to a patient who has recently undergone initial treatment but remains fragile. The financial "vital signs" suggest the company is currently managing to meet its short-term obligations but with a very limited safety margin. The almost negligible equity base signals a high dependency on director loans and internal liquidity.

The business is operating with a micro-entity status, which is typical for start-ups with minimal turnover and staff (average one employee). The financial statements confirm no audit requirement and simplified reporting, which is consistent with the company size but means less external scrutiny of financial health.

The director’s loan balance represents both a lifeline and a risk; while it supports operations, it also signals limited external funding options and potential liquidity constraints if the directors need repayment or if the business faces unforeseen expenses.

---

4. Recommendations: Steps to Improve Financial Wellness

• Build Equity Base: Consider injecting additional share capital or retaining profits to strengthen shareholders’ funds. A stronger equity base improves resilience and creditworthiness.

• Enhance Working Capital: Monitor receivables and payables closely to improve the net current assets buffer. Even a small increase in working capital will provide a healthier cash flow cushion.

• Formalize Financing: Explore external financing options (e.g., small business loans or grants) to reduce dependency on director loans. Formal agreements improve clarity and governance.

• Profitability Focus: As operations continue, prioritize generating sustainable profits to build reserves and reduce reliance on director advances.

• Regular Monitoring: Implement monthly financial reviews to detect early symptoms of cash flow distress, allowing proactive management.

• Plan for Growth: As the company grows beyond micro thresholds, prepare for more rigorous reporting and potential audit requirements.

---